Literature DB >> 10981483

Aluminum exposure in chronic renal failure in iberoamerica at the end of the 1990s: overview and perspectives.

J L Fernández-Martín1, A Canteros, A Alles, P Massari, J Cannata-Andía.   

Abstract

Epidemic aluminum neurotoxicity has virtually disappeared in the dialysis population; however, sporadic toxic effects caused by contamination of water with aluminum are still reported. In this review, the current situation in Iberoamerica is analyzed. Exposure to aluminum through dialysate shows considerable geographical differences even within the same country, including seasonal variability. Sometimes the tap water showed very high aluminum content that does not permit the water treatment system to efficiently remove all the aluminum, forcing the use of water treatment systems with a double reverse-osmosis filter on line. The use of adequate water treatment systems and a correct control policy has improved the quality of the dialysate, minimizing the aluminum exposure. However, an additional problem in Iberoamerica is the difficulty to obtain aluminum-free concentrates for the preparation of the final dialysis solution. Aluminum still seems to be implicated in a great percentage of symptomatic low-bone remodeling lesions in South America compared with Europe, demonstrating that exposure to aluminum through dialysate is still a cause of concern in some areas of the world.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981483     DOI: 10.1097/00000441-200008000-00006

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  3 in total

Review 1.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

2.  Synthesis of Imine-Naphthol Tripodal Ligand and Study of Its Coordination Behaviour towards Fe(III), Al(III), and Cr(III) Metal Ions.

Authors:  Kirandeep Kaur; Minati Baral
Journal:  Bioinorg Chem Appl       Date:  2014-09-08       Impact factor: 7.778

3.  A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial.

Authors:  Jorge B Cannata-Andía; Augusto Díaz-Sottolano; Pehuén Fernández; Manuel Naves-Díaz; Walter Douthat; José L Fernández-Martín; Carmen Palomo-Antequera; Pablo Herrero-Puente; Ricardo Mouzo; Natalia Carrillo-López; Sara Panizo; Guillermo H Ibañez; Carlos A Cusumano; Carolina Ballarino; Vicente Sánchez-Polo; Jacqueline Pefaur-Penna; Irene Maderuelo-Riesco; Jesús Calviño-Varela; Mónica D Gómez; Carlos Gómez-Alonso; John Cunningham
Journal:  BMC Med       Date:  2022-02-18       Impact factor: 8.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.